At the Canadian Myeloma Research Group (CMRG), we advance the understanding and treatment of multiple myeloma through high-impact clinical research and innovation. Our work focuses on generating evidence that drives better therapies, improves outcomes, and accelerates progress for patients across Canada.
Clinical Trials
CMRG leads a broad portfolio of clinical trials evaluating new therapies, treatment combinations, and care strategies. These studies bring cutting-edge options to patients while helping shape the future standard of care in multiple myeloma.
Real-World Evidence
Our national CMRG database—one of Canada’s largest myeloma datasets—captures real-world patient outcomes to complement clinical trials. This evidence deepens understanding of treatment effectiveness, safety, and practice patterns, supporting better decision-making for clinicians, researchers, and policymakers.
Translational
Research & Biobank
CMRG’s translational research and biobanking program focuses on biomarker discovery, target validation, resistance mechanisms, and advanced diagnostic technologies. These efforts deepen understanding of disease biology and treatment response, enabling more precise, personalized therapies.